Polyamines analysis by HPLC and their application as tumor markers. 2012

Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan 250012, China.

Cancers are one of the main causes of human deaths globally. Great effort has been dedicated to the search for sensitive and specific markers of cancer. Polyamines including mainly putrescine (PUT), spermidine (SPD), and spermine (SP), are promising tumor markers since their excretion is frequently elevated in patients with various types of cancers. In the present study, we developed an efficient high performance liquid chromatographic (HPLC) method for the determination of polyamines in human serum using dansyl chloride for pre-column derivatization. All polyamines were separated within 10 min. The analytical method is simple, rapid, and highly reproducible. We applied of 11 cancers as objects of study, and made comparisons between polyamines and other 24 common tumor markers with six indexes: specificity, sensitivity, negative predictive value, positive predictive value, total effective, and the mean value. We drew the conclusion that polyamines are promising tumor markers, and they might be of great value in diagnosing cancers, predicting therapeutic success, or indicating the relapse of tumors.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015317 Biogenic Polyamines Biogenic amines having more than one amine group. These are long-chain aliphatic compounds that contain multiple amino and/or imino groups. Because of the linear arrangement of positive charge on these molecules, polyamines bind electrostatically to ribosomes, DNA, and RNA. Polyamines, Biogenic
D057230 Limit of Detection Concentration or quantity that is derived from the smallest measure that can be detected with reasonable certainty for a given analytical procedure. Limits of Detection,Detection Limit,Detection Limits

Related Publications

Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
January 1981, Critical reviews in clinical laboratory sciences,
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
January 1998, Methods in molecular biology (Clifton, N.J.),
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
February 1981, Archives of neurology,
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
December 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
January 2013, Biomolecules & therapeutics,
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
January 1977, Clinical chemistry,
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
December 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
January 1992, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
January 1988, Journal of cancer research and clinical oncology,
Shanji Fu, and Chen Xiao, and Weiming Zhao, and Xiuping Yu
January 1976, The Italian journal of biochemistry,
Copied contents to your clipboard!